CLASS II Device recall · Reported 2 Dec 2015 · FDA Enforcement Report

Advia Chemistry Hemoglobin A1c_3, A1c_3M Reagent kits recalled

Siemens Healthcare Diagnostics is recalling Advia Chemistry Hemoglobin A1c_3, A1c_3M Reagent kits, distributed in 10 states. The recall was initiated on 24 Sep 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codes10379673 (160 tests kit), 10485591 (800 tests kit) Lot 230 (SMN 10485591 and 10379673) and lot 231(SMN 10485591)
Quantity recalled3031

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0340-2016
FDA event ID
72392
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class II
Status
Terminated
Recall initiated
24 Sep 2015
FDA classified
25 Nov 2015
Reported
2 Dec 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

24 Sep 2015Recall initiated by company
25 Nov 2015Classified by FDA+62 days
2 Dec 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Reagent in these lots may demonstrate an increased occurrence of high %HbA1c bias, a positive bias averaging 0.6% HbA1c units, ranging from -0.1% to 1.1% HbA1c units. The maximum bias was observed at higher %HbA1c concentrations. QC samples may exhibit a similar bias.

Product as listed by the FDA

ADVIA Chemistry Hemoglobin A1c_3, A1c_3M Reagent kits. Used on the ADVIA 1200, 1650, 1800, 2400, and XPT Chemistry Systems. For in vitro diagnostic use in the quantitative determination of Hemoglobin A1c, a diabetes marker, in whole blood on the ADVIA Chemistry systems.

Where it was distributed

Distributed in the states of AZ, NY, CA, IN, LA, MN, OH, MI, NM, and GA, and the countries of Mexico and Canada.

ArizonaCaliforniaGeorgiaIndianaLouisianaMichiganMinnesotaNew MexicoNew YorkOhio

Questions about this recall

Why was it recalled?

Reagent in these lots may demonstrate an increased occurrence of high %HbA1c bias, a positive bias averaging 0.6% HbA1c units, ranging from -0.1% to 1.1% HbA1c units. The maximum bias was observed at higher %HbA1c concentrations. QC samples may exhibit a similar bias.

Which lots are affected?

10379673 (160 tests kit), 10485591 (800 tests kit) Lot 230 (SMN 10485591 and 10379673) and lot 231(SMN 10485591)

Where was it sold?

Distributed in the states of AZ, NY, CA, IN, LA, MN, OH, MI, NM, and GA, and the countries of Mexico and Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Test Kits & Diagnostics recalls

All 2,656